UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 95

Sortiert nach

Clinical use of dendritic cells for cancer therapy

The lancet oncology, 2014-06, Vol.15 (7), p.e257-e267

2014

Volltextzugriff (PDF)

CD56 in the Immune System: More Than a Marker for Cytotoxicity?

Frontiers in immunology, 2017-07, Vol.8, p.892-892

2017

Volltextzugriff (PDF)

A systematic review on poly(I:C) and poly-ICLC in glioblastoma: adjuvants coordinating the unlocking of immunotherapy

Journal of experimental & clinical cancer research, 2021-06, Vol.40 (1), p.1-213, Article 213

2021

Volltextzugriff (PDF)

The Use of TLR7 and TLR8 Ligands for the Enhancement of Cancer Immunotherapy

The oncologist (Dayton, Ohio), 2008-08, Vol.13 (8), p.859-875

2008

Volltextzugriff (PDF)

Induction of complete and molecular remissions in acute myeloid leukemia by Wilms' tumor 1 antigen-targeted dendritic cell vaccination

Proceedings of the National Academy of Sciences - PNAS, 2010-08, Vol.107 (31), p.13824-13829

2010

Volltextzugriff (PDF)

Expansion of a BDCA1+CD14+ Myeloid Cell Population in Melanoma Patients May Attenuate the Efficacy of Dendritic Cell Vaccines

Cancer research (Chicago, Ill.), 2016-08, Vol.76 (15), p.4332-4346

2016

Volltextzugriff (PDF)

Cold atmospheric plasma treatment of melanoma and glioblastoma cancer cells

Plasma processes and polymers, 2016-12, Vol.13 (12), p.1195-1205

2016

Volltextzugriff (PDF)

Interleukin-15 enhances the proliferation, stimulatory phenotype, and antitumor effector functions of human gamma delta T cells

Journal of hematology and oncology, 2016-09, Vol.9 (1), p.101-101, Article 101

2016

Volltextzugriff (PDF)

Dendritic Cells and Programmed Death-1 Blockade: A Joint Venture to Combat Cancer

Frontiers in immunology, 2018-03, Vol.9, p.394-394

2018

Volltextzugriff (PDF)

Interleukin-15 Dendritic Cells Harness NK Cell Cytotoxic Effector Function in a Contact- and IL-15-Dependent Manner

PloS one, 2015-05, Vol.10 (5), p.e0123340-e0123340

2015

Volltextzugriff (PDF)

Expression of SARS-CoV-2-Related Surface Proteins in Non-Small-Cell Lung Cancer Patients and the Influence of Standard of Care Therapy

Cancers, 2022-08, Vol.14 (17), p.4074

2022

Volltextzugriff (PDF)

Auranofin Synergizes with the PARP Inhibitor Olaparib to Induce ROS-Mediated Cell Death in Mutant p53 Cancers

Antioxidants, 2023-03, Vol.12 (3), p.667

2023

Volltextzugriff (PDF)

Optimization of the Solvent and In Vivo Administration Route of Auranofin in a Syngeneic Non-Small Cell Lung Cancer and Glioblastoma Mouse Model

Pharmaceutics, 2022-12, Vol.14 (12), p.2761

2022

Volltextzugriff (PDF)

Interleukin-15-Cultured Dendritic Cells Enhance Anti-Tumor Gamma Delta T Cell Functions through IL-15 Secretion

Frontiers in immunology, 2018-04, Vol.9, p.658-658

2018

Volltextzugriff (PDF)

The potential and controversy of targeting STAT family members in cancer

Seminars in cancer biology, 2020-02, Vol.60, p.41-56

2020

Volltextzugriff (PDF)

Poly(I:C) enhances the susceptibility of leukemic cells to NK cell cytotoxicity and phagocytosis by DC

PloS one, 2011-06, Vol.6 (6), p.e20952-e20952

2011

Volltextzugriff (PDF)

Toll-like receptor 7/8 agonist resiquimod greatly increases the immunostimulatory capacity of human acute myeloid leukemia cells

Cancer Immunology, Immunotherapy, 2010-01, Vol.59 (1), p.35-46

2010

Volltextzugriff (PDF)

Interleukin-15-induced CD56(+) myeloid dendritic cells combine potent tumor antigen presentation with direct tumoricidal potential

PloS one, 2012-12, Vol.7 (12), p.e51851

2012

Volltextzugriff (PDF)

The Search for an Interesting Partner to Combine with PD-L1 Blockade in Mesothelioma: Focus on TIM-3 and LAG-3

Cancers, 2021-01, Vol.13 (2), p.282

2021

Volltextzugriff (PDF)

Dendritic cell-based cancer gene therapy

Human gene therapy, 2009-10, Vol.20 (10), p.1106

2009

Volltextzugriff (PDF)

Dendritic Cell-Based and Other Vaccination Strategies for Pediatric Cancer

Cancers, 2019-09, Vol.11 (9), p.1396

2019

Volltextzugriff (PDF)

Clinical evaluation of cellular immunotherapy in acute myeloid leukaemia

Cancer Immunology, Immunotherapy, 2011-06, Vol.60 (6), p.757-769

2011

Volltextzugriff (PDF)

Induction of cytomegalovirus-specific T cell responses in healthy volunteers and allogeneic stem cell recipients using vaccination with messenger RNA-transfected dendritic cells

Transplantation, 2015-01, Vol.99 (1), p.120

2015

Volltextzugriff (PDF)

Targeting hedgehog signaling in pancreatic ductal adenocarcinoma

Pharmacology & therapeutics (Oxford), 2022-08, Vol.236, p.108107-108107, Article 108107

2022

Volltextzugriff (PDF)

Application of the pMHC Array to Characterise Tumour Antigen Specific T Cell Populations in Leukaemia Patients at Disease Diagnosis

PloS one, 2015-10, Vol.10 (10), p.e0140483-e0140483

2015

Volltextzugriff (PDF)

1 – 25 von 95

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(88)
Mit Volltextzugriff
(88)

Publikationsform

Artikel
(94)
Dissertationen
(1)

Sprache

Englisch
(95)
Japanisch
(15)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Clinical use of dendritic cells for cancer therapy

CD56 in the Immune System: More Than a Marker for Cytotoxicity?

A systematic review on poly(I:C) and poly-ICLC in glioblastoma: adjuvants coordinating the unlocking of immunotherapy

The Use of TLR7 and TLR8 Ligands for the Enhancement of Cancer Immunotherapy

Induction of complete and molecular remissions in acute myeloid leukemia by Wilms' tumor 1 antigen-targeted dendritic cell vaccination

Expansion of a BDCA1+CD14+ Myeloid Cell Population in Melanoma Patients May Attenuate the Efficacy of Dendritic Cell Vaccines

Cold atmospheric plasma treatment of melanoma and glioblastoma cancer cells

Interleukin-15 enhances the proliferation, stimulatory phenotype, and antitumor effector functions of human gamma delta T cells

Dendritic Cells and Programmed Death-1 Blockade: A Joint Venture to Combat Cancer

Interleukin-15 Dendritic Cells Harness NK Cell Cytotoxic Effector Function in a Contact- and IL-15-Dependent Manner

Expression of SARS-CoV-2-Related Surface Proteins in Non-Small-Cell Lung Cancer Patients and the Influence of Standard of Care Therapy

Auranofin Synergizes with the PARP Inhibitor Olaparib to Induce ROS-Mediated Cell Death in Mutant p53 Cancers

Optimization of the Solvent and In Vivo Administration Route of Auranofin in a Syngeneic Non-Small Cell Lung Cancer and Glioblastoma Mouse Model

Interleukin-15-Cultured Dendritic Cells Enhance Anti-Tumor Gamma Delta T Cell Functions through IL-15 Secretion

The potential and controversy of targeting STAT family members in cancer

Poly(I:C) enhances the susceptibility of leukemic cells to NK cell cytotoxicity and phagocytosis by DC

Toll-like receptor 7/8 agonist resiquimod greatly increases the immunostimulatory capacity of human acute myeloid leukemia cells

Interleukin-15-induced CD56(+) myeloid dendritic cells combine potent tumor antigen presentation with direct tumoricidal potential

The Search for an Interesting Partner to Combine with PD-L1 Blockade in Mesothelioma: Focus on TIM-3 and LAG-3

Dendritic cell-based cancer gene therapy

Dendritic Cell-Based and Other Vaccination Strategies for Pediatric Cancer

Clinical evaluation of cellular immunotherapy in acute myeloid leukaemia

Induction of cytomegalovirus-specific T cell responses in healthy volunteers and allogeneic stem cell recipients using vaccination with messenger RNA-transfected dendritic cells

Targeting hedgehog signaling in pancreatic ductal adenocarcinoma

Application of the pMHC Array to Characterise Tumour Antigen Specific T Cell Populations in Leukaemia Patients at Disease Diagnosis

Suchergebnisse filtern